医薬品およびバイオ医薬品向けラボ用機器市場

当レポートでは、医薬品およびバイオ医薬品向けラボ用機器市場について調査し、医薬品・バイオ分野で使用される主要な技術を徹底的に調査しながら、9カテゴリー50の技術を網羅しています。また、過去の成長を検証し、今後5年間の需要予測を提供しています。創薬の段階、治療法の焦点、治療薬開発で直面する課題に関する洞察を提供することに重点を置いています。

目次

第1章 イントロダクション

• 報告の背景
• 範囲と定義
• エグゼクティブサマリー

第2章 医薬品/バイオセクターの背景

第3章 市場の需要

• 全体的需要
• ライフサイエンス機器
• 分子生物学
• クロマトグラフィ
• 質量分析
• ラボオートメーション
• 原子分光法
• バイオプロセシング
• イメージング
• その他の技術

第4章 付録

Drug development is a long and complicated process that involves several types of analytical instruments used in a variety of ways and purposes. Starting at early discovery, a targeted process occurs during drug and biomarker discovery to identifying a drug candidate. These drug candidates are then tested in preclinical and clinical trials, translational research, and finally manufacturing and QA/QC. Due to the nature of drugs and their interactions, knowing how a drug works, its side effects, the method of delivery, it's efficacy, consistency in manufacturing, and more all must be tested using precise methods and accurate data. The instruments covered in this report are the primary sources for that data and form the critical infrastructure for pharmaceutical and biotherapeutic compounds. Further, innovations in the instruments, software controlling them, and analysis methods will further drive new biotherapeutics and drug formulations that are key to the success of the industry.

At the heart of all drug development is the pharmaceutical, biotech, and biopharmaceutical companies. They account for the majority of demand for these instruments, as they are the main commercial benefactors of biotherapeutics. These companies will often utilize contract research organizations and public sector organizations such as those in academia, the government, and research institutions to assist in the R&D process. Together and in conjunction with a regulatory framework, this network alongside instrument suppliers form a fast growing marketplace that has only been further helped by steady government investment. Future growth in the pharma/bio marketplace will be driven by new therapeutic modalities that are more specific to certain disease, delivered in better ways, with faster research and production timelines, and an increased reliance on personalization to patients. The resulting price tag and need for specific capital and infrastructure will further reliance on high throughput screening, automation, and reliance on CROs and CMOs that provide expertise and scale up resources.

“ Lab Instrumentation Markets for Pharmaceuticals and Biopharmaceuticals ” is an in-depth examination of the major technologies used in the pharma/bio sector, encompassing 50 technologies in 9 categories. The report examines historical growth and provides forecasts for demand over the next five years. This report focuses on delivering insights into phases of discovery, therapeutic focus, and the challenges being faced in therapeutics development.

Top Vendors include:

Table of Contents

I. Introduction

• A. Report Background
• B. Scope & Definitions
• C. Executive Summary

II. Background on the Pharma/Bio Sector

III. Market Demand

• A. Overall Demand
• B. Life Science Instrumentation
• C. Molecular Biology
• D. Chromatography
• E. Mass Spectrometry
• F. Lab Automation
• G. Atomic Spectroscopy
• H. Bioprocessing
• I. Imaging
• J. Other Techniques

IV. Appendix

• A. Recent & Upcoming Reports from SDi